Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 30;19(1):33-39.
doi: 10.31083/j.rcm.2018.01.896.

Coronary Chronic Total Occlusion (CTO): A Review

Affiliations
Review

Coronary Chronic Total Occlusion (CTO): A Review

Christian O Koelbl et al. Rev Cardiovasc Med. .

Abstract

Coronary artery chronic total occlusions (CTO) are frequently encountered during coronary angiography; however percutaneous recanalization has historically been technically challenging and an important determinant for referral to coronary artery bypass surgery or for medical therapy alone. Recent advances in interventional equipment and innovative approaches to crossing CTO have significantly increased the success rate of percutaneous treatment. Although there is only one relevant randomized control trial (RCT) performed to date, several large, nonrandomized studies have consistently reported improvement in clinical outcomes, including improved survival and relief of angina, when successful percutaneous treatment of CTO was compared with unsuccessful revascularization. These positive observational results have encouraged the initiation of several RCTs which will provide more robust evidence on clinical outcomes of CTO-PCI compared with guideline-directed medical therapy (GDMT) alone.

Keywords: Chronic total occlusion (CTO); coronary artery disease (CAD); percutaneous coronary intervention (PCI); stable Ischemic Heart Disease (SIHD).

PubMed Disclaimer

Conflict of interest statement

Christian Koelbl: The author declares no competing interest. Zoran Nedeljkovic: The author declares no competing interest. Alice Jacobs: Site PI, Abbott Vascular.

MeSH terms

Substances